ラボ製品およびサービスのアウトソーシングの世界市場

ラボ製品およびサービスのアウトソーシングの世界市場は2030年までに622億米ドルに達する見込み

2024年に405億米ドルと推定されるラボ製品およびサービスのアウトソーシングの世界市場は、2024年から2030年にかけてCAGR 7.4%で成長し、2030年には622億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるラボ製品タイプは、CAGR 8.6%を記録し、分析期間終了時には439億米ドルに達すると予測されます。ラボラトリーサービスタイプの成長率は、分析期間中CAGR 5.0％と推定されます。

米国市場は推定110億米ドル、中国はCAGR11.8%で成長予測

米国のラボ製品およびサービスのアウトソーシング市場は2024年に110億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに133億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.6%と7.2%と予測されています。欧州では、ドイツがCAGR 4.9%で成長すると予測されています。

世界のラボ製品およびサービスのアウトソーシング市場- 主要動向と促進要因のまとめ

なぜアウトソーシングはラボ業界のゲームチェンジャーになりつつあるのか？

世界のラボ製品およびサービスのアウトソーシング市場は、検査室、製薬会社、研究機関が、費用対効果が高く高品質な検査ソリューションを求めて、外部サービスプロバイダーを利用するようになっているため、需要が大幅に急増しています。アウトソーシングは、業務の合理化、リソースの最適化、創薬、臨床研究、診断の進歩の加速における重要な戦略となっています。研究所のプロセスが複雑化し、規制要件も厳しくなっていることから、企業は研究開発業務受託機関（CRO）、研究開発製造業務受託機関（CDMO）、独立系検査機関に専門知識を求めるようになっています。

試験所サービスにおけるアウトソーシングの主要な促進要因の一つは、社内の試験所運営に関連するコストの上昇です。最先端の研究施設を設立・維持するには、インフラ、熟練した人材、設備、コンプライアンス管理などに多額の投資が必要となります。ラボ試験、分析サービス、データ処理をアウトソーシングすることで、組織は間接費を削減し、中核となる研究活動に集中することができます。さらに、アウトソーシングによって、研究室は継続的な資本支出を必要とせずに最先端技術や革新的な手法にアクセスできるようになり、既存の製薬会社にとっても、新興のバイオテクノロジー企業にとっても魅力的な選択肢となります。

技術の進歩はどのようにラボのアウトソーシングを形成しているのか？

検査室アウトソーシング市場は、特に自動化、人工知能（AI）、クラウドベースの検査室情報管理システム（LIMS）などの技術革新から多大な恩恵を受けています。自動化はサンプル処理、ハイスループット・スクリーニング、品質管理に革命をもたらし、契約ラボはより迅速で正確な検査ソリューションを提供できるようになりました。ロボットによるワークフローの統合は、効率をさらに高め、人的ミスを減らし、データの再現性を向上させています。こうした進歩により、外部委託検査サービスの信頼性とコスト効率が向上し、外部プロバイダーと提携する企業が増えています。

AIとビッグデータ分析もまた、データ管理、予測モデリング、規制遵守を合理化することで、検査室アウトソーシングに変革的な役割を果たしてきました。AI主導のアルゴリズムは、大規模なデータセットを高い精度で分析し、バイオマーカー探索、薬剤スクリーニング、個別化医療への取り組みを支援することができます。さらに、クラウドベースのLIMSの採用は、リアルタイムのデータ共有、遠隔モニタリング、検査報告書への安全なアクセスを可能にすることで、アウトソーシング・パートナーと顧客とのコラボレーションを向上させています。こうしたデジタルの進歩により、アウトソーシングされたラボ業務の拡張性と柔軟性が向上し、組織は物理的なインフラの制約を受けずに研究能力を拡大できるようになりました。

市場は製薬・バイオテクノロジー分野以外にも拡大？

アウトソーシングされたラボ製品やサービスは、従来は製薬会社やバイオテクノロジー企業が主なユーザーであったが、環境試験、飲食品安全、法医学分析、臨床診断など、多様な業界に市場が拡大しています。消費財や工業製品における厳格な品質管理の必要性の高まりが、第三者試験所検査サービスへの需要を後押ししています。さらに、世界中の規制当局がより厳格なコンプライアンス基準を実施しているため、さまざまな分野の企業が製品の安全性と規制遵守を確保するためにラボ試験をアウトソーシングするようになっています。

精密医療と遺伝子検査の台頭は、特にゲノム配列決定、個別化医薬品開発、希少疾患診断において、外部委託検査サービスの需要をさらに促進しています。臨床検査室やヘルスケア機関は、次世代シーケンシング（NGS）技術、分子診断、AIを活用した予測分析にアクセスするため、専門のアウトソーシング企業と提携するケースが増えています。さらに、COVID-19パンデミックは、大規模な診断検査、疫学調査、ワクチン研究においてアウトソーシングされた検査室サービスの重要な役割を実証し、市場の地位をさらに強化しました。

臨床検査アウトソーシング市場を促進する主な成長要因は何か？

ラボ製品およびサービスのアウトソーシング市場の成長は、研究開発費の増加、コスト効率の高いラボ運営に対する需要の高まり、技術の進歩、規制当局の圧力など、いくつかの要因によってもたらされます。主な成長要因の一つは、医薬品開発コストの高騰であり、このため製薬企業やバイオテクノロジー企業は前臨床試験や臨床試験を専門のCROやCDMOにアウトソーシングするようになっています。アウトソーシングにより、企業はFDA、EMA、ICHガイドラインなどの厳しい規制枠組みへの準拠を維持しながら、新薬の市場投入までの時間を短縮することができます。

市場拡大を後押しするもう一つの大きな要因は、ラボ用試薬、アッセイキット、消耗品の受託製造の採用が増加していることです。ラボのワークフローが高度化するにつれ、高品質で標準化されたラボ製品のニーズが急増し、外部メーカーへの依存度が高まっています。さらに、検査室の自動化とデジタル化への注目が高まるにつれ、検査室情報学におけるアウトソーシングの役割が強化され、AI主導の分析、遠隔診断、クラウドベースのデータストレージのシームレスな統合が可能になりました。

環境検査や食品安全といった非医薬品分野への検査室アウトソーシングの拡大も市場成長に寄与しています。汚染、公害、食中毒に対する懸念の高まりが検査規制の厳格化につながり、第三者検査室による検証の需要が増加しています。さらに、持続可能で環境に優しい試験所慣行が重視されるようになったことで、組織はグリーンケミストリー、廃棄物削減、エネルギー効率の高いプロセスを専門とする認定試験所に試験サービスを委託するようになっています。

さらに、研究協力や国境を越えた臨床試験の世界化が、外部委託検査サービスの必要性をさらに高めています。製薬企業が新興市場に事業を拡大する中、アウトソーシングは臨床研究、規制遵守試験、市場固有の製品評価を実施するための費用対効果が高く、拡張性のあるソリューションを提供します。臨床検査技術の継続的な進歩は、専門知識に対する需要の高まりと相まって、今後数年間、臨床検査アウトソーシング市場の堅調な成長を維持すると予想されます。

セグメント

タイプ（ラボ製品タイプ、ラボサービスタイプ）、技術（免疫測定技術、分子診断技術、微生物学技術、臨床化学技術、フローサイトメトリー技術、質量分析技術、クロマトグラフィー技術、その他技術）、エンドユーザー（製薬・バイオ企業エンドユーザー、医療機器企業エンドユーザー、CRO・CDMOエンドユーザー、その他エンドユーザー）

調査対象企業の例

• Agilent Technologies
• Avantor（VWR International）
• Bio-Rad Laboratories
• Charles River Laboratories
• Covance Inc.
• Eurofins Scientific
• ICON plc
• Intertek Group plc
• IQVIA
• Labcorp
• Medpace Holdings, Inc.
• Parexel International Corporation
• PerkinElmer
• PPD, Inc.
• PRA Health Sciences
• Quest Diagnostics
• SGS SA
• Syneos Health
• Thermo Fisher Scientific
• WuXi AppTec, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界固有のSLMにクエリーする代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Laboratory Products and Services Outsourcing Market to Reach US$62.2 Billion by 2030

The global market for Laboratory Products and Services Outsourcing estimated at US$40.5 Billion in the year 2024, is expected to reach US$62.2 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2024-2030. Laboratory Products Type, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$43.9 Billion by the end of the analysis period. Growth in the Laboratory Services Type segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$11.0 Billion While China is Forecast to Grow at 11.8% CAGR

The Laboratory Products and Services Outsourcing market in the U.S. is estimated at US$11.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$13.3 Billion by the year 2030 trailing a CAGR of 11.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 7.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.9% CAGR.

Global Laboratory Products and Services Outsourcing Market - Key Trends & Drivers Summarized

Why Is Outsourcing Becoming a Game-Changer in the Laboratory Industry?

The global laboratory products and services outsourcing market has witnessed a significant surge in demand as laboratories, pharmaceutical companies, and research institutions increasingly turn to external service providers for cost-effective and high-quality testing solutions. Outsourcing has become a key strategy in streamlining operations, optimizing resources, and accelerating drug discovery, clinical research, and diagnostic advancements. The rising complexity of laboratory processes, coupled with stringent regulatory requirements, has prompted organizations to seek specialized expertise from contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), and independent testing laboratories.

One of the major drivers of outsourcing in laboratory services is the rising costs associated with in-house laboratory operations. Establishing and maintaining state-of-the-art research facilities requires substantial investments in infrastructure, skilled personnel, equipment, and compliance management. By outsourcing laboratory testing, analytical services, and data processing, organizations can reduce overhead expenses and focus on core research activities. Additionally, outsourcing enables laboratories to access cutting-edge technologies and innovative methodologies without the need for continuous capital expenditure, making it an attractive option for both established pharmaceutical firms and emerging biotech startups.

How Are Technological Advancements Reshaping Laboratory Outsourcing?

The laboratory outsourcing market has benefited immensely from technological innovations, particularly in automation, artificial intelligence (AI), and cloud-based laboratory information management systems (LIMS). Automation has revolutionized sample processing, high-throughput screening, and quality control, enabling contract laboratories to offer faster and more precise testing solutions. The integration of robotic workflows has further enhanced efficiency, reducing human errors and improving data reproducibility. These advancements have made outsourced laboratory services more reliable and cost-effective, encouraging more companies to partner with external providers.

AI and big data analytics have also played a transformative role in laboratory outsourcing by streamlining data management, predictive modeling, and regulatory compliance. AI-driven algorithms can analyze large datasets with high accuracy, aiding in biomarker discovery, drug screening, and personalized medicine initiatives. Additionally, the adoption of cloud-based LIMS has improved collaboration between outsourcing partners and clients by enabling real-time data sharing, remote monitoring, and secure access to laboratory reports. These digital advancements have increased the scalability and flexibility of outsourced laboratory operations, allowing organizations to expand their research capabilities without physical infrastructure constraints.

Is the Market Expanding Beyond Pharmaceutical and Biotechnology Sectors?

While pharmaceutical and biotechnology companies have traditionally been the primary users of outsourced laboratory products and services, the market is expanding into diverse industries, including environmental testing, food and beverage safety, forensic analysis, and clinical diagnostics. The increasing need for stringent quality control in consumer goods and industrial products has driven demand for third-party laboratory testing services. Additionally, regulatory authorities worldwide are enforcing more rigorous compliance standards, prompting companies across various sectors to outsource laboratory testing to ensure product safety and regulatory adherence.

The rise of precision medicine and genetic testing has further fueled the demand for outsourced laboratory services, particularly in genomic sequencing, personalized drug development, and rare disease diagnostics. Clinical laboratories and healthcare institutions are increasingly partnering with specialized outsourcing firms to access next-generation sequencing (NGS) technologies, molecular diagnostics, and AI-powered predictive analytics. Moreover, the COVID-19 pandemic demonstrated the critical role of outsourced laboratory services in large-scale diagnostic testing, epidemiological studies, and vaccine research, further strengthening the market’s position.

What Are the Key Growth Drivers Fueling the Laboratory Outsourcing Market?

The growth in the laboratory products and services outsourcing market is driven by several factors, including rising R&D expenditures, increasing demand for cost-efficient laboratory operations, technological advancements, and regulatory pressures. One of the primary growth drivers is the escalating cost of drug development, which has prompted pharmaceutical and biotechnology firms to outsource preclinical and clinical testing to specialized CROs and CDMOs. Outsourcing allows companies to reduce time-to-market for new drugs while maintaining compliance with stringent regulatory frameworks such as FDA, EMA, and ICH guidelines.

Another major factor fueling market expansion is the increasing adoption of contract manufacturing for laboratory reagents, assay kits, and consumables. As laboratory workflows become more sophisticated, the need for high-quality, standardized laboratory products has surged, leading to greater reliance on external manufacturers. Additionally, the growing focus on laboratory automation and digitalization has reinforced the role of outsourcing in laboratory informatics, enabling seamless integration of AI-driven analytics, remote diagnostics, and cloud-based data storage.

The expansion of laboratory outsourcing into non-pharmaceutical sectors, such as environmental testing and food safety, has also contributed to market growth. Rising concerns about contamination, pollution, and foodborne diseases have led to stricter testing regulations, increasing demand for third-party laboratory verification. Additionally, the growing emphasis on sustainable and eco-friendly laboratory practices has prompted organizations to outsource testing services to accredited laboratories that specialize in green chemistry, waste reduction, and energy-efficient processes.

Moreover, the globalization of research collaborations and cross-border clinical trials has further driven the need for outsourced laboratory services. As pharmaceutical companies expand their operations into emerging markets, outsourcing provides a cost-effective and scalable solution for conducting clinical research, regulatory compliance testing, and market-specific product evaluations. The ongoing advancements in laboratory technologies, coupled with the increasing demand for specialized expertise, are expected to sustain the robust growth of the laboratory outsourcing market in the coming years.

SCOPE OF STUDY:

The report analyzes the Laboratory Products and Services Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Laboratory Products Type, Laboratory Services Type); Technology (Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology, Chromatography Technology, Other Technologies); End-Use (Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

• Agilent Technologies
• Avantor (VWR International)
• Bio-Rad Laboratories
• Charles River Laboratories
• Covance Inc.
• Eurofins Scientific
• ICON plc
• Intertek Group plc
• IQVIA
• Labcorp
• Medpace Holdings, Inc.
• Parexel International Corporation
• PerkinElmer
• PPD, Inc.
• PRA Health Sciences
• Quest Diagnostics
• SGS SA
• Syneos Health
• Thermo Fisher Scientific
• WuXi AppTec, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Laboratory Products and Services Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Pressure for Cost Reduction Drives Growth in Laboratory Services Outsourcing
  • Increasing Demand for Advanced and Specialized Testing Accelerates Outsourcing Trends
  • Technological Advancements in Lab Automation Strengthen the Business Case for Outsourcing
  • Rising Complexity of Laboratory Research Fuels Demand for External Expertise and Services
  • Regulatory Compliance and Quality Assurance Requirements Drive Laboratory Outsourcing
  • Focus on Streamlining Operations Spurs Growth in Outsourced Laboratory Testing Services
  • Expansion of Healthcare Infrastructure and Emerging Markets Accelerates Outsourcing Opportunities
  • Collaborations Between Biotech and Pharmaceutical Companies Drive Laboratory Services Outsourcing
  • The Growing Need for Faster Time-to-Market for Pharmaceuticals Spurs Demand for Outsourcing
  • Globalization and the Expansion of Global Supply Chains Drive Demand for Outsourced Lab Services
  • Emerging Focus on Personalized Medicine and Genomics Increases Outsourced Service Demands
  • Stronger Emphasis on Sustainability and Environmental Regulations Drives Outsourcing of Environmental Testing
  • Demand for Clinical Trials and Drug Development Services Generates Opportunities for Laboratory Outsourcing
  • Increase in Cross-Border Outsourcing of Laboratory Services Expands Market Reach
  • Innovation in Laboratory Technologies and Research Drives the Outsourcing of Non-Core Services
  • Surge in Contract Research Organizations (CROs) Expands the Need for Outsourced Laboratory Services
  • Growing Focus on R&D Investment in Healthcare Fuels the Demand for Laboratory Services Outsourcing
  • Rising Demand for Laboratory Services in Diagnostic Testing and Molecular Research
  • Regulatory Changes in Global Markets Drive the Need for Outsourced Expertise in Compliance and Testing
  • Increased Adoption of Cloud Technologies and Data Analytics Propels the Outsourcing of Laboratory Services
  • Rising Pressure on Lab Capacity and Workforce Constraints Accelerate the Shift Towards Outsourcing
  • Technological Integration Between Lab Equipment and Outsourced Providers Enhances Operational Efficiency
  • Demand for Integrated End-to-End Lab Solutions Drives Outsourcing Adoption
  • Increased Focus on Clinical and Pre-Clinical Studies Boosts Outsourcing of Testing and Lab Services
  • Global Shift Toward Decentralized and Remote Testing Drives Laboratory Services Outsourcing
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Laboratory Products and Services Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Laboratory Products and Services Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Laboratory Products and Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Laboratory Products Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Laboratory Products Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Laboratory Products Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Laboratory Services Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Laboratory Services Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Laboratory Services Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Immunoassays Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Immunoassays Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Molecular Diagnostics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Molecular Diagnostics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Microbiology Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Microbiology Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Clinical Chemistry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Clinical Chemistry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Flow Cytometry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Mass Spectroscopy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Mass Spectroscopy Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Mass Spectroscopy Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Chromatography Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Chromatography Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Pharmaceutical & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Pharmaceutical & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Medical Device Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Medical Device Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for CRO & CDMO End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for CRO & CDMO End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for CRO & CDMO End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Laboratory Products and Services Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Laboratory Products and Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Laboratory Products and Services Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Laboratory Products and Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Laboratory Products and Services Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Laboratory Products and Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Laboratory Products and Services Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Laboratory Products and Services Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Laboratory Products and Services Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Laboratory Products and Services Outsourcing by Type - Laboratory Products Type and Laboratory Services Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Laboratory Products and Services Outsourcing by Type - Percentage Breakdown of Value Sales for Laboratory Products Type and Laboratory Services Type for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Laboratory Products and Services Outsourcing by Technology - Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Laboratory Products and Services Outsourcing by Technology - Percentage Breakdown of Value Sales for Other Technologies, Immunoassays Technology, Molecular Diagnostics Technology, Microbiology Technology, Clinical Chemistry Technology, Flow Cytometry Technology, Mass Spectroscopy Technology and Chromatography Technology for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Laboratory Products and Services Outsourcing by End-Use - Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Laboratory Products and Services Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotech Companies End-Use, Medical Device Companies End-Use, CRO & CDMO End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION